GMV Chart, page-1846

I disagree on the lack of communication. Company just recently put out an update under "company presentation" In that presentation, it was clearly outlined their direction and where future sales will be coming from.
In April and May, there was an update from Yacov and yesterday quarterly provided guidance on GMedDX .

We will not get an update on the CFDA until it has been approved full stop! The company is not going to update every little detail on the process and there is no reason why it should. No update on where it is,will stop any selling, in fact it will do the opposite and any announcement stating a delay will send share price crashing further.

CFDA is out of GMV hand and there is nothing Yacov can do about it. If you look at the expected financial for Q2, you will see they allocated $700000 for manufacturing cost and ended up spending $280000 and have allocated $750000 for this Q.

They have their hands tied and can not update share holders on when it will finally come through, they can only guess on the information they are told and with that, allocate money towards the manufacturing cost on approval.

Too much focus is on the CFDA and many are missing the cream of the crop with IDTF business and future earnings